168 related articles for article (PubMed ID: 28590335)
1. Technological methods to measure adherence to antiretroviral therapy and preexposure prophylaxis.
Garrison LE; Haberer JE
Curr Opin HIV AIDS; 2017 Sep; 12(5):467-474. PubMed ID: 28590335
[TBL] [Abstract][Full Text] [Related]
2. Point-of-care and Near Real-time Testing for Antiretroviral Adherence Monitoring to HIV Treatment and Prevention.
Drain PK; Bardon AR; Simoni JM; Cressey TR; Anderson P; Sevenler D; Olanrewaju AO; Gandhi M; Celum C
Curr HIV/AIDS Rep; 2020 Oct; 17(5):487-498. PubMed ID: 32627120
[TBL] [Abstract][Full Text] [Related]
3. Role of medication therapy management in preexposure prophylaxis therapy for HIV prevention.
Ferrell KW; Woodard LM; Woodard TJ
J Pharm Pract; 2015 Feb; 28(1):10-2. PubMed ID: 25500557
[TBL] [Abstract][Full Text] [Related]
4. Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice.
Haberer JE
Curr Opin HIV AIDS; 2016 Jan; 11(1):10-7. PubMed ID: 26633638
[TBL] [Abstract][Full Text] [Related]
5. Ingestible Electronic Sensors for Monitoring Real-time Adherence to HIV Pre-exposure Prophylaxis and Antiretroviral Therapy.
Goodman GR; Vaz C; Albrechta H; Boyer EW; Mayer KH; O'Cleirigh C; Chai PR
Curr HIV/AIDS Rep; 2022 Oct; 19(5):433-445. PubMed ID: 36048309
[TBL] [Abstract][Full Text] [Related]
6. Medication adherence among men who have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis implementation.
Liu AY; Hessol NA; Vittinghoff E; Amico KR; Kroboth E; Fuchs J; Irvin R; Sineath RC; Sanchez T; Sullivan PS; Buchbinder SP
AIDS Patient Care STDS; 2014 Dec; 28(12):622-7. PubMed ID: 25396706
[TBL] [Abstract][Full Text] [Related]
7. Cell Phone-Based and Adherence Device Technologies for HIV Care and Treatment in Resource-Limited Settings: Recent Advances.
Campbell JI; Haberer JE
Curr HIV/AIDS Rep; 2015 Dec; 12(4):523-31. PubMed ID: 26439917
[TBL] [Abstract][Full Text] [Related]
8. The preexposure prophylaxis revolution; from clinical trials to programmatic implementation.
Mugo NR; Ngure K; Kiragu M; Irungu E; Kilonzo N
Curr Opin HIV AIDS; 2016 Jan; 11(1):80-6. PubMed ID: 26575147
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of interactive text message response (ITR) as a novel, real-time measure of adherence to antiretroviral therapy for HIV+ youth.
Dowshen N; Kuhns LM; Gray C; Lee S; Garofalo R
AIDS Behav; 2013 Jul; 17(6):2237-43. PubMed ID: 23546844
[TBL] [Abstract][Full Text] [Related]
10. Evidence for Technology Interventions to Promote ART Adherence in Adult Populations: a Review of the Literature 2012-2015.
Amico KR
Curr HIV/AIDS Rep; 2015 Dec; 12(4):441-50. PubMed ID: 26412085
[TBL] [Abstract][Full Text] [Related]
11. Actionable Adherence Monitoring: Technological Methods to Monitor and Support Adherence to Antiretroviral Therapy.
Bell KM; Haberer JE
Curr HIV/AIDS Rep; 2018 Oct; 15(5):388-396. PubMed ID: 30232578
[TBL] [Abstract][Full Text] [Related]
12. Antiretroviral Preexposure Prophylaxis: Opportunities and Challenges for Primary Care Physicians.
Mayer KH; Krakower DS; Boswell SL
JAMA; 2016 Mar; 315(9):867-8. PubMed ID: 26893026
[No Abstract] [Full Text] [Related]
13. Opportunities and Challenges of Digital Technology for HIV Treatment and Prevention.
Simoni JM; Kutner BA; Horvath KJ
Curr HIV/AIDS Rep; 2015 Dec; 12(4):437-40. PubMed ID: 26412082
[TBL] [Abstract][Full Text] [Related]
14. Adherence Measurements in HIV: New Advancements in Pharmacologic Methods and Real-Time Monitoring.
Castillo-Mancilla JR; Haberer JE
Curr HIV/AIDS Rep; 2018 Feb; 15(1):49-59. PubMed ID: 29380227
[TBL] [Abstract][Full Text] [Related]
15. HIV Preexposure Prophylaxis "Smart Pill" in Early Testing.
Abbasi J
JAMA; 2018 Sep; 320(10):965. PubMed ID: 30208436
[No Abstract] [Full Text] [Related]
16. A Clinical Home for Preexposure Prophylaxis: Diverse Health Care Providers' Perspectives on the "Purview Paradox".
Hoffman S; Guidry JA; Collier KL; Mantell JE; Boccher-Lattimore D; Kaighobadi F; Sandfort TG
J Int Assoc Provid AIDS Care; 2016; 15(1):59-65. PubMed ID: 26293904
[TBL] [Abstract][Full Text] [Related]
17. Maximizing the Benefits of HIV Preexposure Prophylaxis.
Buchbinder SP
Top Antivir Med; 2018 Apr; 25(4):138-142. PubMed ID: 29689539
[TBL] [Abstract][Full Text] [Related]
18. I Can See Clearly Now: Using Active Visualisation to Improve Adherence to ART and PrEP.
Jones AS; Petrie KJ
AIDS Behav; 2017 Feb; 21(2):335-340. PubMed ID: 27873082
[TBL] [Abstract][Full Text] [Related]
19. Systemic preexposure prophylaxis for HIV: translating clinical data to clinical practice.
Li J; Dufrene SL; Okulicz JF
Ann Pharmacother; 2014 Apr; 48(4):507-18. PubMed ID: 24473492
[TBL] [Abstract][Full Text] [Related]
20. Shifting the Narrative of Preexposure Prophylaxis Adherence Counseling for Cisgender Women.
Sheth AN; Momplaisir F; Dumond JB
JAMA; 2024 Mar; 331(11):912-914. PubMed ID: 38427361
[No Abstract] [Full Text] [Related]
[Next] [New Search]
